Vulcan Two Group float on AIM
September 2025
Vulcan Two Group plc is a new investment company that has been established to acquire companies or businesses that the Directors believe have the potential to generate Shareholder value.
The Directors will focus on acquiring companies in the ePharmacy market and will initially focus on businesses operating substantially in the UK. The company wants to “lead the consolidation of the private prescription sector – one of the fastest growing and most profitable sectors of the UK pharmacy market”.
The Group’s two Executive Directors, Michael Kraftman and Brendan O’Brien, have leading experience in the eCommerce healthcare sector, having built Vision Direct, one of Europe’s leading online contact lens suppliers, between 2009 and 2021.
Placing and Admission to trading on AIM
On 3rd September 2025 admission and the first day of dealings commenced by way of a Placing of and Subscription for 6,000,000 New Ordinary Shares at 200 pence per New Ordinary Share.
The Perivan shareholder communications team was delighted to work with Canaccord Genuity Limited who acted as Nominated Adviser and Broker to Vulcan Two on the successful production and publication of the 88-page admission document.
For further information, click here.
Perivan is the market leader for IPO admission document production and specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies, private companies, and open and closed-ended funds.